Skip to main content
. 2017 May 5;130(9):1012–1018. doi: 10.4103/0366-6999.204928

Table 4.

Adverse pregnancy outcomes in different OGTT subgroups

Groups Non-GDM (n = 11,814) GDM

Group I Group II Group III (n = 201)


IF (n = 1370) I1 (n = 385) I2 (n = 427) IIF+1 (n = 161) IIF+2 (n = 95) II1+2 (n = 288)
Cesarean delivery 4790 (40.6) 683 (50.0)* 172 (44.7) 186 (43.6) 94 (58.4)* 55 (57.9)* 133 (46.3) 112 (56.0)*
Macrosomia 861 (7.3) 149 (10.9)* 32 (8.3) 29 (6.8) 21 (13.0)* 16 (16.8)* 12 (4.2)* 24 (12.0)*
LGA 694 (5.9) 143 (10.5)* 34 (8.8)* 25 (5.8) 16 (9.9)* 16 (16.8)* 5 (5.2)* 167 (12.0)*
Preterm birth 588 (5.0) 74 (5.4) 20 (5.2) 30 (7.0) 10 (6.2) 8 (8.4) 21 (7.3) 21 (10.5)
Neonatal complication 1314 (11.2) 177 (13.0)* 46 (12.0) 60 (14.2) 20 (12.6) 15 (15.8) 40 (14.0) 28 (14.2)
SGA 611 (5.2) 50 (3.7)* 15 (3.9) 25 (5.8)†,‡ 4 (2.5) 3 (3.2)|| 9 (3.1)|| 9 (4.5)

Data are presented as n (%). *P<0.05 versus non-GDM Group; P<0.001 versus Group IF; P<0.001 versus Group I1; §P<0.001, versus Group II1+2; ||P<0.001 versus Group IIF+1. Group I: GDM patients with one abnormal value on the OGTT; Subgroups IF, I1, and I2 were diagnosed as GDM according to a single abnormal value for fasting hyperglycemia, 1-h and 2-h hyperglycemia, respectively; Group II: GDM diagnosed by two abnormal values; Group III: GDM patients with three abnormal values on the OGTT. GDM: Gestational diabetes mellitus; LGA: Large for gestational age; SGA: Small for gestational age; OGTT: Oral glucose tolerance test.